- Current report filing (8-K)
September 08 2011 - 5:30PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): September 8, 2011
ROCHESTER MEDICAL
CORPORATION
(Exact name of registrant as
specified in its charter)
|
|
|
|
|
Minnesota
|
|
0-18933
|
|
41-1613227
|
(State or other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
|
|
|
One Rochester Medical Drive,
Stewartville, MN
|
|
55976
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrant’s telephone number,
including area code:
(507) 533-9600
|
Not
Applicable
|
(Former name or former address if changed since last report.)
|
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Item 7.01. Regulation FD Disclosure.
The following information is being furnished in accordance with General Instruction B.2 of
Form 8-K and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section,
nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of
1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such
filing.
Furnished herewith as Exhibit 99.1 and incorporated by reference herein is a copy of
presentation materials prepared by Rochester Medical Corporation for use at investor conferences.
Item 9.01. Financial Statements and Exhibits.
Reference is made to the Exhibit Index hereto with respect to the exhibits furnished herewith.
The exhibits listed in the Exhibit Index hereto are being furnished in accordance with General
Instruction B.2 of Form 8-K and shall not be deemed filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the
liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing
under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by
specific reference in such filing.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Date: September 8, 2011
|
|
|
|
|
|
ROCHESTER MEDICAL CORPORATION
|
|
|
By:
|
/s/ David A. Jonas
|
|
|
|
David A. Jonas
|
|
|
|
Chief Financial Officer
|
|
EXHIBIT INDEX
|
|
|
Exhibit No.
|
|
Description
|
|
99.1
|
|
Presentation materials prepared by Rochester Medical Corporation
|
Rochester Medical Corp. (MM) (NASDAQ:ROCM)
Historical Stock Chart
From Apr 2024 to May 2024
Rochester Medical Corp. (MM) (NASDAQ:ROCM)
Historical Stock Chart
From May 2023 to May 2024